Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
4-((1-butyl-3-(4-(4-(1-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)butanamido)phenyl)ureido)methyl)-N-hydroxybenzamide
ID: ALA5269955
Chembl Id: CHEMBL5269955
Max Phase: Preclinical
Molecular Formula: C42H48N10O9
Molecular Weight: 836.91
Associated Items: